These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12589024)

  • 1. A Saccharomyces cerevisiae mutant with increased virulence.
    Wheeler RT; Kupiec M; Magnelli P; Abeijon C; Fink GR
    Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2766-70. PubMed ID: 12589024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KRE5 gene null mutant strains of Candida albicans are avirulent and have altered cell wall composition and hypha formation properties.
    Herrero AB; Magnelli P; Mansour MK; Levitz SM; Bussey H; Abeijon C
    Eukaryot Cell; 2004 Dec; 3(6):1423-32. PubMed ID: 15590817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and characterization of baker's yeast capable of strongly activating a macrophage.
    Takada Y; Nishino Y; Ito C; Watanabe H; Kanzaki K; Tachibana T; Azuma M
    FEMS Yeast Res; 2014 Mar; 14(2):261-9. PubMed ID: 24118943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Cell Wall Proteins in Saccharomyces cerevisiae Clinical Isolates Elucidates Hsp150p in Virulence.
    Hsu PH; Chiang PC; Liu CH; Chang YW
    PLoS One; 2015; 10(8):e0135174. PubMed ID: 26270963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Saccharomyces cerevisiae mutant displaying beta-glucans on cell surface.
    Sakai Y; Azuma M; Takada Y; Umeyama T; Kaneko A; Fujita T; Igarashi K; Ooshima H
    J Biosci Bioeng; 2007 Feb; 103(2):161-6. PubMed ID: 17368399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of the frequency of petite formation by isolates of Saccharomyces cerevisiae with virulence.
    Weger SD; Ganji A; Clemons KV; Byron JK; Minn Y; Stevens DA
    Med Mycol; 2002 Apr; 40(2):161-8. PubMed ID: 12058729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion of the CaBIG1 gene reduces beta-1,6-glucan synthesis, filamentation, adhesion, and virulence in Candida albicans.
    Umeyama T; Kaneko A; Watanabe H; Hirai A; Uehara Y; Niimi M; Azuma M
    Infect Immun; 2006 Apr; 74(4):2373-81. PubMed ID: 16552067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of genetic interactions between DHH1, SSD1 and ELM1 indicates their involvement in cellular morphology determination in Saccharomyces cerevisiae.
    Moriya H; Isono K
    Yeast; 1999 Apr; 15(6):481-96. PubMed ID: 10234786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo virulence of commercial Saccharomyces cerevisiae strains with pathogenicity-associated phenotypical traits.
    de Llanos R; Llopis S; Molero G; Querol A; Gil C; Fernández-Espinar MT
    Int J Food Microbiol; 2011 Jan; 144(3):393-9. PubMed ID: 21081253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MyD88-dependent Toll-like receptor signaling is required for murine macrophages response to IS2.
    Li H; Kim WJ; Jiang J; Lee SH; Youn HS; Moon EY; Kim TJ; Ye SK; Ryu JH; Kang TB; Koppula S; Park PJ; Choi DK; Lee KH
    Int Immunopharmacol; 2011 Oct; 11(10):1578-83. PubMed ID: 21628003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of soluble β-(1-3),(1-6)-D-glucan from Saccharomyces cerevisiae in the murine P388 ascites tumor model.
    Harnack U; Eckert K; Pecher G
    In Vivo; 2011; 25(2):185-9. PubMed ID: 21471533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of spaceflight on polysaccharides of Saccharomyces cerevisiae cell wall.
    Liu HZ; Wang Q; Liu XY; Tan SS
    Appl Microbiol Biotechnol; 2008 Dec; 81(3):543-50. PubMed ID: 18797865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-tumor metastatic activity of beta-glucan purified from mutated Saccharomyces cerevisiae.
    Yoon TJ; Kim TJ; Lee H; Shin KS; Yun YP; Moon WK; Kim DW; Lee KH
    Int Immunopharmacol; 2008 Jan; 8(1):36-42. PubMed ID: 18068098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for Proinflammatory β-1,6 Glucans in the Pneumocystis carinii Cell Wall.
    Kottom TJ; Hebrink DM; Jenson PE; Gudmundsson G; Limper AH
    Infect Immun; 2015 Jul; 83(7):2816-26. PubMed ID: 25916991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of beta-glucans and chitin in a Saccharomyces cerevisiae cell wall mutant using high-performance liquid chromatography.
    Hong Z; Mann P; Shaw KJ; Didomenico B
    Yeast; 1994 Aug; 10(8):1083-92. PubMed ID: 7992508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in Fks1p affect the cell wall content of beta-1,3- and beta-1,6-glucan in Saccharomyces cerevisiae.
    Dijkgraaf GJ; Abe M; Ohya Y; Bussey H
    Yeast; 2002 Jun; 19(8):671-90. PubMed ID: 12185837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid content of microparticulate (1-->3)-beta-D-glucan isolated from Saccharomyces cerevisiae.
    Müller A; Mayberry W; Acuff R; Thedford S; Browder W; Williams D
    Microbios; 1994; 79(321):253-61. PubMed ID: 7837997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased synthesis of alkali-soluble glucan in a cell-wall mutant of Saccharomyces cerevisiae.
    Blagoeva J; Venkov P
    Biochem Int; 1990 Dec; 22(5):791-5. PubMed ID: 2151557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenicity of Saccharomyces cerevisiae in complement factor five-deficient mice.
    Byron JK; Clemons KV; McCusker JH; Davis RW; Stevens DA
    Infect Immun; 1995 Feb; 63(2):478-85. PubMed ID: 7822013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to the plant PR-5 protein osmotin in the model fungus Saccharomyces cerevisiae is mediated by the regulatory effects of SSD1 on cell wall composition.
    Ibeas JI; Yun DJ; Damsz B; Narasimhan ML; Uesono Y; Ribas JC; Lee H; Hasegawa PM; Bressan RA; Pardo JM
    Plant J; 2001 Feb; 25(3):271-80. PubMed ID: 11208019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.